Clinical Trials Logo

Malignant Neoplasms of Brain clinical trials

View clinical trials related to Malignant Neoplasms of Brain.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00643097 Active, not recruiting - Clinical trials for Malignant Neoplasms of Brain

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

ACTIVATe
Start date: September 2007
Phase: Phase 2
Study type: Interventional

RATIONALE: Vaccines made from a peptide may help the body build an effective immune response to kill tumor cells. Colony-stimulating factors, such as GM-CSF, increase the number of white blood cells and platelets found in bone marrow or peripheral blood. Giving vaccine therapy after surgery may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial is studying how well vaccine therapy works in treating patients with newly diagnosed glioblastoma multiforme.